Alterola Biotech Inc
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailabil… Read more
Alterola Biotech Inc (ABTI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.382x
Based on the latest financial reports, Alterola Biotech Inc (ABTI) has a cash flow conversion efficiency ratio of 0.382x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-860.57K) by net assets ($-2.25 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Alterola Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Alterola Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Alterola Biotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alterola Biotech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HOLOGIC
MU:HO1
|
0.072x |
|
Earthwise Minerals Corp.
F:966
|
0.105x |
|
E79 Resources Corp
OTCQB:ESVNF
|
-0.060x |
|
FINMECCANICA - Dusseldorf Stock Exchang
DU:FMNB
|
0.046x |
|
DKSH HLDG N
MU:DS5
|
N/A |
|
AKER -A-
BE:FKM
|
N/A |
|
SYNAPTICS
BE:SJN
|
-0.008x |
|
Bengal Energy Ltd
PINK:BNGLF
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Alterola Biotech Inc (2009–2024)
The table below shows the annual cash flow conversion efficiency of Alterola Biotech Inc from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-03-31 | $-1.33 Million | $-1.45 Million | 1.088x | +1156.71% |
| 2023-09-30 | $10.10 Million | $-1.04 Million | -0.103x | 0.00% |
| 2023-03-31 | $10.10 Million | $-1.04 Million | -0.103x | -2637.78% |
| 2022-09-30 | $10.93 Million | $44.34K | 0.004x | 0.00% |
| 2022-03-31 | $10.93 Million | $44.34K | 0.004x | +102.96% |
| 2021-09-30 | $-323.22K | $44.34K | -0.137x | -322.28% |
| 2021-03-31 | $-323.22K | $-19.95K | 0.062x | -82.81% |
| 2020-09-30 | $-55.57K | $-19.95K | 0.359x | -- |
| 2020-03-31 | $-323.22K | $0.00 | 0.000x | -- |
| 2019-09-30 | $-202.71K | $0.00 | 0.000x | -- |
| 2018-09-30 | $-264.05K | $-27.63K | 0.105x | 0.00% |
| 2018-03-31 | $-264.05K | $-27.63K | 0.105x | +54.57% |
| 2017-09-30 | $-294.68K | $-19.95K | 0.068x | -35.30% |
| 2016-09-30 | $-264.05K | $-27.63K | 0.105x | +45.48% |
| 2016-03-31 | $-241.47K | $-17.37K | 0.072x | 0.00% |
| 2015-09-30 | $-241.47K | $-17.37K | 0.072x | -8.13% |
| 2015-03-31 | $-205.34K | $-16.08K | 0.078x | -61.60% |
| 2014-09-30 | $-150.43K | $-30.67K | 0.204x | 0.00% |
| 2014-03-31 | $-150.43K | $-30.67K | 0.204x | -66.55% |
| 2013-09-30 | $-101.68K | $-61.99K | 0.610x | -72.17% |
| 2011-03-31 | $-57.52K | $-126.00K | 2.190x | 0.00% |
| 2010-09-30 | $-57.52K | $-126.00K | 2.190x | +110.70% |
| 2010-03-31 | $4.85K | $-99.22K | -20.463x | 0.00% |
| 2009-09-30 | $4.85K | $-99.22K | -20.463x | -- |